- Nnodu et al, HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges, Blood Cells Mol Dis. 2019 Feb 8, doi: 10.1016/j.bcmd.2019.01.007
Although care has been taken to provide material and information that is accurate we are not liable for loss arising from reliance on information contained in this site or other sites that may be linked to from our site. The views and opinions of non-Consortium Members that appear on the website do not necessarily reflect the views of the Consortium. The material and information on the SADaCC Website do not necessarily reflect the views of the funders. You agree to use this site only for lawful purposes. If you do not accept these Terms and Conditions, you will cease using this site immediately.
Copyright © 2022 SADaCC